Concomitant medical products plc141400/16545692, plc201200/16336107, and pxl161407/15506387.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and / or require intervention include, but are not limited to renal failure and death.(b)(4).
|
On (b)(6) 2018, the patient underwent endovascular repair of abdominal aortic and common iliac artery aneurysms using gore® excluder® aaa endoprostheses (rlt261412/17495820, plc141400/16545692, plc201200/16336107, and pxl161407/15506387).Prior to the initial procedure, chronic total occlusion (cto) had existed in the patient¿s right external iliac artery.Additionally, pre-existing calcification and stenosis were revealed in the patient¿s left leg, from the left external iliac to the left femoral arteries.Pre-dilation of the left external iliac artery was performed, and a 16-fr gore® dryseal flex introducer sheath was inserted into an intended position.Then, the cto lesion in the right external iliac artery was also dilated, and a 12-fr gore® dryseal flex introducer sheath was advanced.Trunk-ipsilateral leg and contralateral leg components were advanced and deployed from the left side, followed by contralateral and iliac extender components being implanted in the right side.Final angiography did not reveal endoleaks, and the patient tolerated the procedure.On (b)(6) 2018, the patient suffered from acute renal failure.Later on the same day, the patient got in cardiac arrest and expired.It was reported that the patient had not urinated post initial implant procedure, so the physician suspected an acute renal failure.Additionally, a possible cause of death was acute renal failure but an exact cause of death was unknown as an autopsy was not performed.
|